Language Select
Varian Logo

Recent News

November 16, 2017
Varian Medical Systems (NYSE: VAR) today announced it has received Shonin approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market in Japan the Varian Halcyon™ system,... Read more
November 14, 2017
Understanding the important role nurse navigators play in guiding cancer patients through their treatment process, Varian Medical Systems (NYSE: VAR) will be showcasing its new nurse navigation and survivorship solution November 16-19 in Orlando, FL at the AONN+ Navigation & Survivorship Conference, booth #609. This new solution is part of Varian’s 360 Oncology™, a web-based care management platform that integrates relevant health information so patients and their care teams can collaborate on the best care. Read more
November 06, 2017
ALGIERS, Algeria, Nov. 6, 2017 /PRNewswire/ -- Cancer patients in Algeria now have access to modern radiotherapy care with the commencement of treatments at two of six public hospitals currently being equipped by Varian (NYSE: VAR), the world leader in radiotherapy equipment and software. Treatments delivered using linear accelerators including Algeria's first TrueBeam™ systems are being delivered at Sidi-Bel-Abbes and Tlemcen Hospitals in the west of the country. Read more

Recent Blog Posts

Oct 24, 2017 | Centerline
Doctors at the University Hospitals of Geneva (HUG) have begun to utilize the Calypso® GPS for the body® technology to enhance the accuracy of radiotherapy in the treatment of lung cancer.... Read more
Sep 20, 2017 | Spot ON Blog
Varian will be showcasing it's ProBeam® Proton Therapy System, configurable single-room and multi-room solutions with 360 degree gantries. Along with other several advanced technologies... Read more
Aug 30, 2017 | Centerline
Filippo Alongi, MD, director of radiation oncology at Sacro Cuore Don Calabria Cancer Care Center (Negrar-Verona, Italy), recently became the first clinician to use HyperArc™ high-definition... Read more

Corporate Communications Contacts

Corporate Communications Contacts

Corporate Communications Contacts

Mark Plungy
Director, Public Relations
650.424.5630
[email protected]

Mike Bruff
VP, Investor Relations
1 650 424 5163
[email protected]

Neil Madle
Director, Corporate Communications/Investor Relations, Europe
+44 (0)7786 526 068
[email protected]